検索結果 - Sharlene Gill
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer 著者: Eric Van Cutsem, Walter L. Vervenne, Jaafar Bennouna, Yves Humblet, Sharlene Gill, Jean‐Luc Van Laethem, Chris Verslype, Werner Scheithauer, Aijing Shang, Jan Cosaert, Malcolm J. Moore
出版事項 2009Artigo -
9
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study 著者: Steven R. Alberts, Nathan R. Foster, Roscoe F. Morton, J. W. Kugler, Paul Schaefer, Martin Wiesenfeld, Tom R. Fitch, Preston D. Steen, G.P. Kim, Sharlene Gill
出版事項 2005Artigo -
10
-
11
Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada 著者: Brandon S. Sheffield, Shantanu Banerji, Allen Chankowsky, Shaan Dudani, Sharlene Gill, Zuzanna Gorski, Shaqil Kassam, Cassandra Macaulay, Mita Manna, Kirstin Perdrizet, Ravi Ramjeesingh, Monika Slovinec D’Angelo, Filomena Servidio-Italiano
出版事項 2025Artigo -
12
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer T... 著者: Preet Paul Singh, Qian Shi, Nathan R. Foster, Axel Grothey, Suresh Nair, Emily Chan, Anthony F. Shields, Richard M. Goldberg, Sharlene Gill, Morton S. Kahlenberg, Frank A. Sinicrope, Daniel J. Sargent, Steven R. Alberts
出版事項 2016Artigo -
13
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer 著者: Frank A. Sinicrope, Qian Shi, Fabienne Hermitte, Tyler Zemla, Bernhard Mlecnik, Al B. Benson, Sharlene Gill, Richard M. Goldberg, Morton S. Kahlenberg, Suresh Nair, Anthony F. Shields, Thomas C. Smyrk, Jérôme Galon, Steven R. Alberts
出版事項 2020Artigo -
14
Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much? 著者: Sharlene Gill, Charles L. Loprinzi, Daniel J. Sargent, Stephan D. Thomé, Steven R. Alberts, Daniel G. Haller, Jacqueline Benedetti, Guido Francini, Lois E. Shepherd, Jean François Seitz, Roberto Labianca, Wei Chen, S. Stephen, Michael P. Heldebrant, Richard M. Goldberg
出版事項 2004Artigo -
15
Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinoma 著者: Han Chong Toh, Pei‐Jer Chen, Brian I. Carr, Jennifer J. Knox, Sharlene Gill, Peter Ansell, Evelyn McKeegan, Barry L. Dowell, Michelle Pedersen, Qin Qin, Jiang Qian, Frank A. Scappaticci, Justin L. Ricker, Dawn M. Carlson, Wei Peng Yong
出版事項 2012Artigo -
16
Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma 著者: Morris Sherman, Kelly W. Burak, Jean A. Maroun, Peter Metrakos, Jennifer J. Knox, Robert P. Myers, Maha Guindi, Geoffrey A. Porter, John R. Kachura, Pasteur Rasuli, Sharlene Gill, Peter Ghali, Prosanto Chaudhury, J. Siddiqui, David Valenti, Alan Weiss, Ralph Wong
出版事項 2011Artigo -
17
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults 著者: D. Gwyn Bebb, Shantanu Banerji, Normand Blais, Patrice Desmeules, Sharlene Gill, Andrea Grin, Harriet Feilotter, Aaron R. Hansen, Martin Hyrcza, Monika K. Krzyzanowska, Barbara Melosky, Jonathan Noujaim, Bibiana Purgina, Dean Ruether, Christine Simmons, Denis Soulières, Emina Torlakovic, Ming‐Sound Tsao
出版事項 2021Artigo -
18
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update 著者: Nancy N. Baxter, Erin B. Kennedy, Emily K. Bergsland, Jordan Berlin, Thomas J. George, Sharlene Gill, Philip J. Gold, A. Hantel, Lee Jones, Christopher H. Lieu, Najjia N. Mahmoud, Arden M. Morris, Érika Ruiz-García, Y. Nancy You, Jeffrey A. Meyerhardt
出版事項 2021Revisão -
19
Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer 著者: Steven R. Alberts, Daniel J. Sargent, Suresh Nair, Michelle R. Mahoney, Margaret Mooney, Stephen N. Thibodeau, Thomas C. Smyrk, Frank A. Sinicrope, Emily Chan, Sharlene Gill, Morton S. Kahlenberg, Anthony F Shields, James T. Quesenberry, Thomas A. Webb, Gist H. Farr, Barbara A. Pockaj, Axel Grothey, Richard M. Goldberg
出版事項 2012Artigo -
20
LBA65 The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelim... 著者: D. J. Renouf, Jennifer J. Knox, Petr Kavan, Derek J. Jonker, Stephen Welch, Félix Couture, Frédéric Lemay, Mustapha Tehfé, Mohammed Harb, Nathalie Aucoin, Y-J. Ko, Patricia A. Tang, Ravi Ramjeesingh, Brandon M. Meyers, C. Kim, David F. Schaeffer, Jonathan M. Loree, Sharlene Gill, D. Tu, C. O'Callaghan
出版事項 2020Artigo
関連主題
Medicine
Internal medicine
Cancer
Oncology
Colorectal cancer
Clinical endpoint
Disease
Gastroenterology
Gemcitabine
Oxaliplatin
Randomized controlled trial
Biology
Chemotherapy
Clinical trial
Confidence interval
FOLFOX
Family medicine
Hazard ratio
Pancreatic cancer
Surgery
Adjuvant therapy
Chemistry
Computer science
Gerontology
Intensive care medicine
Law
Pathology
Political science
Proportional hazards model
Sociology